Analyst Ratings for Apogee Therapeutics Inc (APGE)
APGE Rating Summary
APGE Price Target Summary
- Highest: $137.00 (BTIG)
- Lowest: $82.00 (BofA Securities)
- Average: $103.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.07 (+41.1%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$103.07 (+41.1%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/22/2026 | RBC Capital » Updated 3/2/2026 |
Brian Abrahams | Downgrade | Sector Perform (Outperform) |
82.00 (83.00) |
81.91 (73.05) |
-10.82% | Details |
| 1/7/2026 | UBS | Michael Yee | New Coverage | Buy (N/A) |
100.00 (N/A) |
77.51 (73.05) |
-5.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
